Oxford Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-191,847
| Closed | -$505K | – | 1377 |
|
|
2019
Q4 | $505K | Sell |
191,847
-57,070
| -23% | -$150K | 0.01% | 1230 |
|
|
2019
Q3 | $896K | Sell |
248,917
-9,488
| -4% | -$34.2K | 0.02% | 991 |
|
|
2019
Q2 | $871K | Buy |
258,405
+81,089
| +46% | +$273K | 0.02% | 1038 |
|
|
2019
Q1 | $484K | Buy |
177,316
+35,538
| +25% | +$97K | 0.01% | 1224 |
|
|
2018
Q4 | $394K | Buy |
141,778
+67,574
| +91% | +$188K | 0.01% | 1291 |
|
|
2018
Q3 | $300K | Sell |
74,204
-92,275
| -55% | -$373K | 0.01% | 1493 |
|
|
2018
Q2 | $853K | Sell |
166,479
-63,462
| -28% | -$325K | 0.02% | 1121 |
|
|
2018
Q1 | $1.26M | Buy |
229,941
+33,474
| +17% | +$183K | 0.03% | 821 |
|
|
2017
Q4 | $1.61M | Sell |
196,467
-33,992
| -15% | -$279K | 0.03% | 695 |
|
|
2017
Q3 | $2.42M | Sell |
230,459
-47,293
| -17% | -$496K | 0.05% | 527 |
|
|
2017
Q2 | $3.07M | Buy |
277,752
+2,563
| +0.9% | +$28.3K | 0.06% | 396 |
|
|
2017
Q1 | $2.3M | Sell |
275,189
-3,849
| -1% | -$32.2K | 0.06% | 412 |
|
|
2016
Q4 | $1.94M | Buy |
279,038
+80,515
| +41% | +$559K | 0.07% | 331 |
|
|
2016
Q3 | $1.01M | Sell |
198,523
-116,304
| -37% | -$592K | 0.03% | 517 |
|
|
2016
Q2 | $1.88M | Buy |
314,827
+159,834
| +103% | +$954K | 0.06% | 379 |
|
|
2016
Q1 | $705K | Buy |
154,993
+84,519
| +120% | +$384K | 0.02% | 551 |
|
|
2015
Q4 | $319K | Buy |
+70,474
| New | +$319K | 0.01% | 746 |
|